LMAT — LEMAITRE VASCULAR INC
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1158895 ·
Last close
$81.52
Market Cap
$1.86B
52W High
$117.37
52W Low
$78.22
ADV30
298,473
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 66,551,000 | 48,396,000 | 17,775,000 | 15,679,000 | 629,526,000 | 26,851,000 | 222,904,000 |
| Dec 2025 | 64,453,000 | 46,190,000 | 18,832,000 | 15,582,000 | 615,690,000 | 28,244,000 | 222,174,000 |
| Sep 2025 | 61,046,000 | 45,955,000 | 20,312,000 | 17,362,000 | 598,069,000 | 25,494,000 | 219,146,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$87,305,000
Investing CF
$-73,742,000
Financing CF
$-12,520,000
CapEx
$-8,183,000
Dividends Paid
$-19,303,000
Buybacks
—
EPS Diluted TTM
$2.85
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$194,683,000
Inventory
$57,767,000
Receivables
$35,770,000
ST Investments
$340,382,000
EBIT TTM
$85,809,000
Pretax Income TTM
$80,615,000
Interest Exp TTM
$5,194,000
Analysts
8
Yahoo Snapshot (yfinance, live)
Total Revenue
$262,432,000
EBITDA
$83,021,000
Free Cash Flow
$49,263,624
Enterprise Value
$1,657,047,424
Total Cash
$376,240,000
Total Debt
$190,254,000
Shares Out
22,869,257
Trailing EPS
$2.86
Book Value
$18.38
ROE
16.8%
ROA
7.4%
Div Yield
1.24%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 249,602,000 | 67,912,000 | 57,734,000 | 615,690,000 | 222,174,000 | 393,516,000 | 81,251,000 |
| Dec 2024 | 219,863,000 | 52,256,000 | 44,038,000 | 551,817,000 | 214,527,000 | 337,290,000 | 44,124,000 |
| Dec 2023 | 193,484,000 | 37,197,000 | 30,105,000 | 346,778,000 | 48,878,000 | 297,900,000 | 36,751,000 |
| Dec 2022 | 161,651,000 | 29,936,000 | 20,636,000 | 310,476,000 | 42,275,000 | 268,201,000 | 25,378,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$3.18
Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $80.00 · spot: $81.52 · call volume: 51 · put volume: 15
Expected Move to 2026-12-18:
±$12.00
(14.72%) —
implied range
$69.52 –
$93.52
· ATM straddle on $80.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| XRAY | DENTSPLY SIRONA Inc. | $1.87B | $9.40 | — |
| BLFS | BIOLIFE SOLUTIONS INC | $1.88B | $38.49 | — |
| NVCR | NovoCure Ltd | $1.84B | $15.84 | — |
| ESTA | ESTABLISHMENT LABS HOLDINGS INC. | $1.97B | $65.97 | — |
| INSP | Inspire Medical Systems, Inc. | $2.04B | $70.50 | — |
News headlines (Yahoo Finance, 1h cache)
LeMaitre Vascular (LMAT) Stock Looks Fully Priced On Its 57% Five Year Run
2026-09-24 03:25 · Yahoo
2 Profitable Stocks to Target This Week and 1 We Ignore
2026-09-21 09:18 · Yahoo
Speculative Rally Weighed on LeMaitre Vascular (LMAT)
2026-09-01 13:06 · Yahoo
LeMaitre to Participate at Upcoming Investor Conferences in September
2026-08-27 20:51 · Yahoo
The Top 5 Analyst Questions From LeMaitre’s Q2 Earnings Call
2026-08-13 08:37 · Yahoo
LeMaitre Vascular (LMAT) Q2 2026 Earnings Call Transcript
2026-08-12 00:30 · Yahoo
LeMaitre Vascular Q2 Earnings Call Highlights
2026-08-05 01:04 · Yahoo
LeMaitre Vascular (LMAT) Q2 Earnings and Revenues Lag Estimates
2026-08-04 23:00 · Yahoo
PAHC or LMAT: Which Is the Better Value Stock Right Now?
2026-09-02 15:40 · Yahoo
LeMaitre Vascular (LMAT) Hit by Profit Taking
2026-08-06 12:51 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.